# Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder

> **NCT05307770** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 25 (actual)

## Conditions studied

- Rapid Eye Movement Sleep Behavior Disorder
- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Immediate Release Melatonin
- **DIETARY_SUPPLEMENT:** Extended Release Melatonin

## Key facts

- **NCT ID:** NCT05307770
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307770, "Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05307770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*